Diabetes drug may increase risk of cardiovascular complications
According to a study published inThe BMJ, Rosiglitazone, a drug used to treat type 2 diabetes, may increase the risk of cardiovascular complications.Medical News Today
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Avandia | Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Endocrinology | Heart | Study